德琪医药-B（06996）今日盘中大涨7.65%，引起了市场的广泛关注。
消息面上，公司发布了截至2025年12月31日止的年度业绩。报告显示，集团收入达到人民币1.05亿元，同比增长14.56%；研发开支为1.69亿元，同比减少34.69%；年内亏损为2.39亿元，同比减少25.10%；经调整年内亏损为2.33亿元，同比收窄23.50%。
公告指出，收入增长主要得益于中国内地市场贡献加速，市场渗透率稳步提升以及商业化合作不断深化。这些积极的财务数据，尤其是亏损的大幅收窄，增强了投资者对公司未来盈利能力的信心，从而推动了股价的显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.